发明申请
- 专利标题: Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
- 专利标题(中): 11β-羟基类固醇脱氢酶的循环抑制剂1
-
申请号: US13381123申请日: 2010-06-30
-
公开(公告)号: US20120232050A1公开(公告)日: 2012-09-13
- 发明人: David A. Claremon , Katerina Leftheris , Linghang Zhuang , Colin M. Tice , Suresh B. Singh , Yuanjie Ye , Wei Zhao
- 申请人: David A. Claremon , Katerina Leftheris , Linghang Zhuang , Colin M. Tice , Suresh B. Singh , Yuanjie Ye , Wei Zhao
- 申请人地址: US PA Fort Washington
- 专利权人: Vitae Pharmaceuticals, Inc.
- 当前专利权人: Vitae Pharmaceuticals, Inc.
- 当前专利权人地址: US PA Fort Washington
- 国际申请: PCT/US10/40641 WO 20100630
- 主分类号: A61K31/535
- IPC分类号: A61K31/535 ; C07D413/10 ; A61K31/5355 ; A61P3/04 ; A61P3/00 ; A61P19/10 ; A61P5/48 ; A61P9/12 ; A61P3/06 ; A61P25/28 ; A61P27/06 ; A61P17/02 ; C07D265/10 ; A61P3/08
摘要:
This invention relates to novel compounds of the Formula (I), (II), (II-A), (II-B), (II-C), (II-D), (III). (III-A). (IIII-B). (III-C). (III-D), (III-E) (IV), (IV-A), (IV-B). (IV-C), (IV-D). (V), (V-A), (V-B), (V-C), (V-D), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of cortisol in a cell or the inhibition of the conversion of cortisone to cortisol in a cell.
公开/授权文献
- US08883778B2 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 公开/授权日:2014-11-11
信息查询